FLT4 and lymphedema: Mäkinen et al. (2001) described transgenic mice expressing inactive VEGFR-3 also demonstrated hindlimb lymphedema-like swelling and fibrosis, characterised by regressed lymphatic vessels and impaired lymphangiogenesis.